Celularity (CELUW) Asset Writedowns and Impairment (2020 - 2025)

Celularity (CELUW) has 6 years of Asset Writedowns and Impairment data on file, last reported at $3.0 million in Q4 2025.

• Asset Writedowns and Impairment for Q4 2025 came in at $3.0 million, up 1194.04% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.9 million (up 532.39% YoY), and the FY2025 annual result was $2.9 million, up 532.39% from the prior year.
• Asset Writedowns and Impairment advanced to $3.0 million in Q4 2025 per CELUW's latest filing, from -$98000.0 in the prior quarter.
• Over five years, Asset Writedowns and Impairment peaked at $107.2 million in Q2 2023 and troughed at -$106.6 million in Q4 2023.
• A 5-year average of $355526.3 and a median of $174000.0 in 2021 frame the typical range for Asset Writedowns and Impairment.
• The sharpest annual moves came in 2022 and 2023: Asset Writedowns and Impairment surged 49000.0% in 2022, then plunged 11993.64% in 2023.
• A 5-year view of Asset Writedowns and Impairment shows it stood at $185000.0 in 2021, then soared by 384.32% to $896000.0 in 2022, then sank by 11993.64% to -$106.6 million in 2023, then jumped by 100.22% to $235000.0 in 2024, then jumped by 1194.04% to $3.0 million in 2025.
• Business Quant data shows CELUW's Asset Writedowns and Impairment at $3.0 million in Q4 2025, -$98000.0 in Q3 2025, and $8000.0 in Q2 2025.